Restarting clozapine following Restarting clozapine following leucopenia or neutropenia leucopenia or neutropenia Dunk Dunk et al et al (2006) report rechallenge with (2006) report rechallenge with clozapine of people with either treatmentclozapine of people with either treatmentresistant or treatment-intolerant schizoresistant or treatment-intolerant schizophrenia. A proportion of these may lack phrenia. A proportion of these may lack insight and capacity and may therefore be insight and capacity and may therefore be detained under the Mental Health Act detained under the Mental Health Act 1983 but the authors do not indicate the 1983 but the authors do not indicate the proportion of patients in this group. If a proportion of patients in this group. If a person has been compulsorily detained, person has been compulsorily detained, the treating clinician may require a second the treating clinician may require a second opinion from the Mental Health Act opinion from the Mental Health Act Commission. We are interested in whether Commission. We are interested in whether Dunk Dunk et al et al have any data on this, as in have any data on this, as in the the British National Formulary British National Formulary clozapine clozapine is contraindicated in those who have is contraindicated in those who have previously developed dyscrasia. The previously developed dyscrasia. The Mental Health Act Commission may not Mental Health Act Commission may not provide a second opinion for drugs that provide a second opinion for drugs that are contraindicated. are contraindicated. Dunk Dunk et al et al report a possible alternative report a possible alternative explanation for dyscrasia during first expoexplanation for dyscrasia during first exposure to clozapine in 25 patients. There was sure to clozapine in 25 patients. There was no alternative explanation in the remaining no alternative explanation in the remaining 28 patients. An obvious question that arises 28 patients. An obvious question that arises is whether a patient is more or less likely to is whether a patient is more or less likely to develop dyscrasia on rechallenge if they develop dyscrasia on rechallenge if they have a history of an alternative explanahave a history of an alternative explanation. This would be a very useful predictor tion. This would be a very useful predictor and would be helpful when discussing and would be helpful when discussing the options with the patient prior to the options with the patient prior to rechallenge. rechallenge. what proportion of patients in our cohort were compultion of patients in our cohort were compulsorily detained. We are not aware of any sorily detained. We are not aware of any studies regarding second opinions from studies regarding second opinions from the Mental Health Act Commission in the Mental Health Act Commission in patients undergoing rechallenge with clozapatients undergoing rechallenge with clozapine but would be interested to hear of any. pine but would be interested to hear of any.
We have re-examined our data to deterWe have re-examined our data to determine whether patients were more or less mine whether patients were more or less likely to develop dyscrasia on rechallenge likely to develop dyscrasia on rechallenge if they had a history of an alternative explaif they had a history of an alternative explanation for the first episode of dyscrasia. nation for the first episode of dyscrasia. Out of 53 patients in the cohort, 25 had Out of 53 patients in the cohort, 25 had an alternative explanation for the first an alternative explanation for the first episode and 6 of these (24%) developed a episode and 6 of these (24%) developed a second episode on rechallenge. Out of the second episode on rechallenge. Out of the 28 patients with no alternative explanation 28 patients with no alternative explanation for the first episode of dyscrasia, 14 (50%) for the first episode of dyscrasia, 14 (50%) experienced dyscrasia on rechallenge. experienced dyscrasia on rechallenge. The difference was not significant The difference was not significant ( (P P¼0.05914). The relative risk of 2.08 indi-0.05914). The relative risk of 2.08 indicated that patients with no alternative cated that patients with no alternative explanation may be twice as likely to have explanation may be twice as likely to have a second episode of dyscrasia on rea second episode of dyscrasia on rechallenge as those with an alternative challenge as those with an alternative explanation, but the 95% confidence interexplanation, but the 95% confidence interval was 0.98-6.2. We must stress that alterval was 0.98-6.2. We must stress that alternative explanations for dyscrasia may not native explanations for dyscrasia may not always be reported to the CPMS, therefore always be reported to the CPMS, therefore these figures may not represent the true these figures may not represent the true picture and this aspect of our work should picture and this aspect of our work should be interpreted with caution. be interpreted with caution.
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Risk factors for coronary heart Risk factors for coronary heart disease in people with severe disease in people with severe mental illness mental illness A number of points in the results, dis-A number of points in the results, discussion and conclusions seem unjustified cussion and conclusions seem unjustified and are potentially misleading. For examand are potentially misleading. For example, the statement that patients with SMI ple, the statement that patients with SMI had a significantly raised CHD risk score had a significantly raised CHD risk score is based upon the unadjusted risk. After is based upon the unadjusted risk. After adjustment for age and gender the odds adjustment for age and gender the odds ratio dropped below the level of statistical ratio dropped below the level of statistical significance and fell further to a nonsignificance and fell further to a nonsignificant value of 1.3 (95% CI 0.7-2.7) significant value of 1.3 (95% CI 0.7-2.7) after considering employment status. The after considering employment status. The authors' claim that 'we have demonstrated authors' claim that 'we have demonstrated that SMI itself can incur CHD risk, that SMI itself can incur CHD risk, over over and above that associated and above that associated with the sociowith the socioeconomic deprivation experienced by these economic deprivation experienced by these patients' patients' is not justified.
is not justified. This claim is repeated in the abstract: This claim is repeated in the abstract: 'excess risk factors for CHD are not wholly 'excess risk factors for CHD are not wholly accounted for by medication or socioaccounted for by medication or socioeconomic deprivation'. This statement economic deprivation'. This statement seems either unproven or reducible to the seems either unproven or reducible to the fact that smoking is more common among fact that smoking is more common among people with SMI. Such a conclusion is people with SMI. Such a conclusion is scarcely novel and clearly does not explain scarcely novel and clearly does not explain the excess mortality observed in patients the excess mortality observed in patients with SMI (Joukamaa with SMI (Joukamaa et al et al, 2006) . The fact , 2006). The fact that diabetes is both more common among that diabetes is both more common among people with SMI and much less explicable people with SMI and much less explicable in terms of their deprivation or demoin terms of their deprivation or demographics receives relatively little comment, graphics receives relatively little comment, despite having particular relevance for their despite having particular relevance for their healthcare needs. healthcare needs.
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